Comparison of Diagnostic Value of Procalcitonin and C-reactive Protein in the Diagnosis of Sepsis in Preterm Neonates: A Systematic Review and Meta-Analysis (2000-2025)

Document Type : systematic review

Authors

1 Neonatal Health Research Center, Research Institute for Children's Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

2 Department of Genetics, Faculty of Advanced Sciences and Technology, TeMS.C, Islamic Azad University, Tehran, Iran.

Abstract

Background: Background: Sepsis remains a leading cause of morbidity and mortality in preterm neonates. Early and accurate diagnosis is crucial for timely intervention. Procalcitonin (PCT) and C-reactive protein (CRP) are commonly used biomarkers for diagnosing neonatal sepsis, but their comparative diagnostic value in preterm neonates is not fully established.
Methods: We conducted a systematic review and meta-analysis of studies published between 2000 and 2025 evaluating the diagnostic accuracy of PCT and CRP for sepsis in preterm neonates. Databases searched included PubMed, Web of Science, and Scopus. Studies were included if they reported sensitivity, specificity, or area under the curve (AUC) for PCT and/or CRP in preterm neonates (<37 weeks gestational age) with suspected or confirmed sepsis. Diagnostic odds ratios (DOR), pooled sensitivity, specificity, and AUC were calculated using random-effects models. Heterogeneity was assessed with I² statistics.
Results: Twelve studies involving 1,842 preterm neonates (678 with confirmed sepsis) met inclusion criteria. Pooled sensitivity and specificity across all studies were 0.81 (95% CI: 0.75–0.86) and 0.85 (95% CI: 0.80–0.89) for PCT, and 0.78 (95% CI: 0.72–0.83) and 0.82 (95% CI: 0.77–0.86) for CRP. Overall AUC values were 0.88 for PCT and 0.83 for CRP. In the subset of seven studies directly comparing both biomarkers within the same cohorts, PCT showed superior accuracy (AUC 0.86 vs. 0.80, p=0.04). Subgroup analysis revealed higher diagnostic accuracy of PCT in LOS (AUC 0.89 vs. 0.82 for CRP).
Conclusions: PCT demonstrates slightly better diagnostic accuracy than CRP for sepsis in preterm neonates, particularly in LOS. However, neither biomarker is perfect, and combination with clinical assessment is recommended. Further studies with standardized cut-offs are needed.

Keywords


  1. Enguix A, Rey C, Concha A, Medina A, Coto D, Diéguez MA. Comparison of procalcitonin with C-reactive protein and serum amyloid for the early diagnosis of bacterial sepsis in critically ill neonates and children. Intensive care medicine. 2001 Jan;27(1):211-5.
  2. Blommendahl J, Janas M, Laine S, Miettinen A, Ashorn P. Comparison of procalcitonin with CRP and differential white blood cell count for diagnosis of culture-proven neonatal sepsis. Scandinavian journal of infectious diseases. 2002 Jan 1;34(8):620-2.
  3. Boo NY, Azlina AN, Rohana J. Usefulness of a semi-quantitative procalcitonin test kit for early diagnosis of neonatal sepsis. Singapore medical journal. 2008 Mar 1;49(3):204.
  4. Cetinkaya M, Özkan H, Köksal N, Celebi S, Hacımustafaoğlu M. Comparison of serum amyloid A concentrations with those of C-reactive protein and procalcitonin in diagnosis and follow-up of neonatal sepsis in premature infants. Journal of Perinatology. 2009 Mar;29(3):225-31.
  5. Jacquot A, Labaune JM, Baum TP, Putet G, Picaud JC. Rapid quantitative procalcitonin measurement to diagnose nosocomial infections in newborn infants. Archives of Disease in Childhood-Fetal and Neonatal Edition. 2009 Sep 1;94(5):F345-8.
  6. Altunhan H, Annagür A, Örs R, Mehmetoğlu I. Procalcitonin measurement at 24 hours of age may be helpful in the prompt diagnosis of early-onset neonatal sepsis. International Journal of Infectious Diseases. 2011 Dec 1;15(12):e854-8.
  7. Naher BS, Mannan MA, Noor K, Shahidullah M. Role of serum procalcitonin and C-reactive protein in the diagnosis of neonatal sepsis. Bangladesh Medical Research Council Bulletin. 2011;37(2):40-6.
  8. Ruan L, Chen GY, Liu Z, Zhao Y, Xu GY, Li SF, et al. The combination of procalcitonin and C-reactive protein or presepsin alone improves the accuracy of diagnosis of neonatal sepsis: a meta-analysis and systematic review. Critical Care. 2018 Nov 21;22(1):316.
  9. Poggi C, Bianconi T, Gozzini E, Generoso M, Dani C. Presepsin for the detection of late-onset sepsis in preterm newborns. Pediatrics. 2015 Jan 1;135(1):68-75.
  10. Aydemir C, Aydemir H, Kokturk F, Kulah C, Mungan AG. The cut-off levels of procalcitonin and C-reactive protein and the kinetics of mean platelet volume in preterm neonates with sepsis. BMC pediatrics. 2018 Aug 1;18(1):253.
  11. Hahn WH, Song JH, Kim H, Park S. Is procalcitonin to C-reactive protein ratio useful for the detection of late onset neonatal sepsis?. The Journal of Maternal-Fetal & Neonatal Medicine. 2018 Mar 19;31(6):822-6.
  12. Berka I, Korček P, Straňák Z. C-reactive protein, interleukin-6, and procalcitonin in diagnosis of late-onset bloodstream infection in very preterm infants. Journal of the Pediatric Infectious Diseases Society. 2021 Nov 1;10(11):1004-8.
  13. Janota J, Stranak Z, Bĕlohlávková S. Interleukin-6, procalcitonin, C-reactive protein and the immature to total neutrophil ratio (I/T) in the diagnosis of early-onset sepsis in low birth weight neonates. Ceska Gynekologie. 2000 Dec 1;65:29-33.
  14. Saeidi R, Akhavan H, Tavakkolafshari J, Shapouri-Moghaddam A. Clinical and biochemical effects of recombinant human granulocyte colony-stimulating factor on the prognosis of preterm infants with early onset neonatal sepsis. Archives of Pediatric Infectious Diseases. 2019 Jan 1;7(1).
  15. Saeidi R, Kazemian M, Noripour S, Fallahi M, Alizadeh P, Kordkatouli M. Comparison of Serum Procalcitonin and C-reactive Protein Levels in Late Onset Neonatal Sepsis. Zahedan Journal of Research in Medical Sciences. 2025 Jul 1;27(27).